Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke
Changjun Yang(Allen Institute for Brain Science), Eduardo Candelario‐Jalil(University of Florida)
Cited by 57
Related Papers
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
|American Journal of Physiology-Cell Physiology|2018|838
Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators
|Journal of Neuroinflammation|2023|31